Adding to the Existing Appeal of Lower Rx Medication Costs Promotes Customer Loyalty

Ability to negotiate prices for certain drugs - a coming victory for Medicare Users

New digital pathology, quantitative image analysis and quantitative AI method for liver tissues is presented for the continuous assessment of the histological phenotype(s) of fibrosis, including severity and regression of fibrosis in Human in-vitro 3D NASH Spheroid models, NASH rodent models, Clinical Phase2b NASH Studies at the Liver Meeting Digital Experience™ 2021

New offering surveys patients; reporting of responses to HCPs drives quicker adoption of promoted therapies

Drug Price Regulation and Additional Factors Create 65% Savings on Drug Costs

Partnership will connect patients to health and wellness-related programs and home delivery to reduce abandonment rates and improve long-term health outcomes.

The biopharma technology company's AI-driven PhAROS™ platform has identified novel, plant-inspired formulations that will be tested using preclinical Zebrafish models at the National Research Council of Canada.

Expanding their mission-based diagnostics services

Demco Automation develops automated manufacturing systems using new robotic technologies to a growing list of industries, including life science, pharmaceuticals, biotech, medical device, defense, aerospace, electronics, commercial/industrial products, semiconductors, and consumer products.

Access to More Affordable Medication Helps Those Sensitive to Rx Med Costs

LFB, a global bio-pharmaceutical group that develops and markets therapeutics for patients with chronic and serious diseases in 30 countries, opens its second location in Florida as 'LFB Plasma.'

Expands access to fertility care nationwide

Acquisition adds significant experience and expertise in the development of liquid, semi-solid, and oral solid dose products for pre-clinical and clinical use, allowing Pace to support a growing number of clients throughout the drug development process.

Caps on Rx medication costs are part of Federal regulations that make drugs cost less in Canada

Hetherington Group and the Healthcare Distribution Alliance Coordinated Efforts to Unite 75+ Industry Leaders and Public Agencies

Offering pharmacies, other healthcare providers, and PBMs a comprehensive portfolio of services, including formulary management, on-demand pharmacy, benefit administration, and rebate aggregation

A New Affordability Platform for Manufacturers of Pharmaceuticals and Other Clinical Products

International Pharmacies in Canada and Elsewhere Able to Dispense Rx Meds for Less

The investment provides CaaMTech with capital to advance compounds from its library into clinical trials